Lenabasum Open-Label Extension Data to be Presented at EULAR 2019 Continue to Show a Favorable Safety Profile and Improvement in Efficacy Outcomes in Systemic Sclerosis and Dermatomyositis Phase 2 Studies

NEXT STORY
Oncotelic Appoints Four Eminent Physician-Scientists Internationally Recognized for their Work in Oncology and Immunology to Newly Established Medical Advisory Board
PREV STORY
Precision Nutrition Opens Personal Coaching Registration: Limited Spots Available for Total Body Transformation Program
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

G1 Therapeutics to Present Data on Trilaciclib at North America Conference on Lung Cancer (NACLC)

author_avatar
NASDAQ Market News

Onconova Therapeutics Announces Promotion for Steven M. Fruchtman, M.D.

New Role as the President involves leadership of the entire product portfolioPromotion reflects progress ...

author_avatar
NASDAQ Market News

Junshi Biosciences and Coherus BioSciences Announce Initiation of Rolling Submission of BLA for Toripalimab to the U.S. FDA for the Treatment of Nasopharyngeal Carcinoma

author_avatar
NASDAQ Market News